Acadia Pharmaceuticals Inc (ACAD) is the 41st largest of 221 Pharmaceuticals companies by market capitalisation, at 4.81 Bn, behind Erasca, Inc. at 5.04 Bn. It trades on a P/E of 12.63, 25% below the peer median of 16.91. The table below compares all 221 on 8 financial metrics.
| # | Ticker | Company | match | industry_code | industry_group | industry_group_code | Market Capitalization | P/E | P/S | Enterprise Value |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | JNJ | Johnson & Johnson | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 663.05 Bn | 31.52 | 6.77 | 642.29 Bn |
| 2 | ABBV | AbbVie Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 452.62 Bn | 71.66 | 7.03 | 446.05 Bn |
| 3 | MRK | Merck & Co., Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 371.61 Bn | 117.26 | 5.58 | 364.47 Bn |
| 4 | NVS | Novartis Ag | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 309.81 Bn | 13.77 | 4.51 | 302.12 Bn |
| 5 | PFE | Pfizer Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 162.46 Bn | 37.19 | 2.55 | 150.76 Bn |
| 6 | SNY | Sanofi | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 53.82 Bn | 11.55 | 1.00 | 46.44 Bn |
| 7 | RVMD | Revolution Medicines, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 44.08 Bn | -24.93 | — | 44.08 Bn |
| 8 | ONC | BeOne Medicines Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 39.98 Bn | 60.98 | 6.52 | 34.89 Bn |
| 9 | INCY | Incyte Corp | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 25.64 Bn | 15.90 | 4.41 | 21.11 Bn |
| 10 | UTHR | UNITED THERAPEUTICS Corp | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 20.84 Bn | 15.89 | 6.61 | 18.17 Bn |
| 11 | NBIX | Neurocrine Biosciences Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 15.71 Bn | 22.27 | 4.66 | 15.32 Bn |
| 12 | JAZZ | Jazz Pharmaceuticals plc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 15.62 Bn | 16.60 | 3.39 | 14.00 Bn |
| 13 | EXEL | Exelixis, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 14.82 Bn | 17.22 | 6.08 | 13.98 Bn |
| 14 | CORT | Corcept Therapeutics Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 11.79 Bn | 217.59 | 14.20 | 11.49 Bn |
| 15 | KYMR | Kymera Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 11.53 Bn | -38.48 | 109.81 | 10.84 Bn |
| 16 | AXSM | Axsome Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 10.70 Bn | -69.62 | 13.78 | 10.38 Bn |
| 17 | GPCR | Structure Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 10.28 Bn | -54.61 | — | 10.28 Bn |
| 18 | NUVL | Nuvalent, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 9.75 Bn | -27.07 | — | 9.75 Bn |
| 19 | CYTK | Cytokinetics Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 9.57 Bn | -13.05 | 141.42 | 8.40 Bn |
| 20 | CRNX | Crinetics Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 8.99 Bn | -17.90 | 213.22 | 8.99 Bn |
| 21 | ALKS | Alkermes plc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 7.75 Bn | 117.19 | 4.65 | 7.09 Bn |
| 22 | BLTE | Belite Bio, Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 6.23 Bn | -80.91 | — | 6.23 Bn |
| 23 | TVTX | Travere Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 6.13 Bn | -141.05 | 10.37 | 6.13 Bn |
| 24 | LQDA | Liquidia Corp | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 6.11 Bn | 44.09 | 13.55 | 5.83 Bn |
| 25 | AMRN | Amarin Corp Plc\Uk | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 5.69 Bn | -209.73 | 30.55 | 5.37 Bn |
| 26 | ACAD | Acadia Pharmaceuticals Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.81 Bn | 12.63 | 4.22 | 3.85 Bn |
| 27 | EWTX | Edgewise Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.61 Bn | -23.36 | — | 4.61 Bn |
| 28 | DFTX | Definium Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.26 Bn | -12.05 | — | 4.26 Bn |
| 29 | INDV | Indivior Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.17 Bn | 11.75 | 3.13 | 3.95 Bn |
| 30 | MANE | Veradermics, Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.99 Bn | -46.30 | — | 3.99 Bn |
| 31 | ELVN | Enliven Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.94 Bn | -46.85 | — | 3.94 Bn |
| 32 | CPRX | CATALYST PHARMACEUTICALS, INC. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.85 Bn | 17.94 | 6.45 | 3.09 Bn |
| 33 | TARS | Tarsus Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.74 Bn | -79.68 | 6.17 | 3.29 Bn |
| 34 | OGN | Organon & Co. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.62 Bn | 17.31 | 0.59 | 2.49 Bn |
| 35 | NAMS | NewAmsterdam Pharma Co N.V. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.13 Bn | -12.07 | 439.70 | 3.13 Bn |
| 36 | TRVI | Trevi Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.69 Bn | -63.79 | — | 2.69 Bn |
| 37 | TAK | Takeda Pharmaceutical Co Ltd | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.65 Bn | 4.61 | 0.06 | -3.15 Bn |
| 38 | SUPN | Supernus Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.55 Bn | -29.99 | 3.24 | 2.18 Bn |
| 39 | HRMY | Harmony Biosciences Holdings, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.45 Bn | 13.71 | 2.55 | 1.64 Bn |
| 40 | NUVB | Nuvation Bio Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.38 Bn | -22.03 | 14.02 | 2.38 Bn |
| 41 | MLYS | Mineralys Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.37 Bn | -6.77 | — | 2.37 Bn |
| 42 | PVLA | Palvella Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.24 Bn | -42.17 | — | 1.92 Bn |
| 43 | AUPH | Aurinia Pharmaceuticals Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.10 Bn | 6.69 | 6.75 | 1.66 Bn |
| 44 | ETON | Eton Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.61 Bn | 169.08 | 16.10 | 1.59 Bn |
| 45 | INVA | Innoviva, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.56 Bn | 7.94 | 3.03 | 0.98 Bn |
| 46 | LBRX | Lb Pharmaceuticals Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.49 Bn | -24.63 | — | 1.49 Bn |
| 47 | XERS | Xeris Biopharma Holdings, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.46 Bn | -85.13 | 4.36 | 1.34 Bn |
| 48 | HROW | Harrow, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.42 Bn | -42.51 | 5.16 | 1.34 Bn |
| 49 | OPK | Opko Health, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.24 Bn | -32.79 | 2.11 | 0.94 Bn |
| 50 | KURA | Kura Oncology, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.17 Bn | -4.91 | 15.15 | 1.17 Bn |
| 51 | OLMA | Olema Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.13 Bn | -5.53 | — | 1.13 Bn |
| 52 | PCRX | Pacira BioSciences, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.04 Bn | 71.04 | 1.39 | 0.79 Bn |
| 53 | LXRX | Lexicon Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.98 Bn | -15.55 | 23.59 | 0.79 Bn |
| 54 | SGP | SpyGlass Pharma, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.97 Bn | -48.80 | — | 0.97 Bn |
| 55 | DSGN | Design Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.95 Bn | -11.79 | — | 0.75 Bn |
| 56 | IVA | Inventiva S.A. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.89 Bn | 9.70 | 179.22 | 0.89 Bn |
| 57 | VSTM | Verastem, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.80 Bn | -6.98 | 9.19 | 0.67 Bn |
| 58 | COLL | Collegium Pharmaceutical, Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.78 Bn | 16.28 | 0.96 | 0.63 Bn |
| 59 | PHAT | Phathom Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.78 Bn | -7.90 | 3.24 | 0.59 Bn |
| 60 | ZVRA | Zevra Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.74 Bn | 12.65 | 5.41 | 0.52 Bn |
| 61 | GYRE | Gyre Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.68 Bn | -36.84 | 5.70 | 0.62 Bn |
| 62 | AQST | Aquestive Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.68 Bn | -8.65 | 12.51 | 0.68 Bn |
| 63 | CRMD | CorMedix Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.67 Bn | 5.29 | 1.78 | 0.41 Bn |
| 64 | MPLT | MapLight Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.63 Bn | -3.13 | — | 0.63 Bn |
| 65 | EOLS | Evolus, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.61 Bn | -17.65 | 1.91 | 0.56 Bn |
| 66 | NVCT | Nuvectis Pharma, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.57 Bn | -18.90 | — | 0.57 Bn |
| 67 | SPRY | ARS Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.56 Bn | -2.52 | 4.77 | 0.41 Bn |
| 68 | OVID | Ovid Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.55 Bn | -16.03 | 349.25 | 0.44 Bn |
| 69 | XFOR | X4 Pharmaceuticals, Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.51 Bn | -5.69 | 32.37 | 0.32 Bn |
| 70 | PALI | Palisade Bio, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.44 Bn | -12.43 | 877.24 | 0.31 Bn |
| 71 | IKT | Inhibikase Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.43 Bn | -6.64 | — | 0.28 Bn |
| 72 | VTVT | vTv Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.41 Bn | -87.07 | 11.24 | 0.41 Bn |
| 73 | ACHV | Achieve Life Sciences, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.37 Bn | — | — | 0.37 Bn |
| 74 | VNDA | Vanda Pharmaceuticals Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.33 Bn | -1.18 | 1.51 | 0.16 Bn |
| 75 | EBS | Emergent BioSolutions Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.32 Bn | -1.82 | 0.42 | 0.18 Bn |
| 76 | SION | Sionna Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.32 Bn | -3.30 | — | 0.32 Bn |
| 77 | IMRX | Immuneering Corp | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.32 Bn | -5.39 | — | 0.32 Bn |
| 78 | TTRX | Turn Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.30 Bn | -39.36 | — | 0.30 Bn |
| 79 | FULC | Fulcrum Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.29 Bn | -3.30 | — | 0.29 Bn |
| 80 | ZNTL | Zentalis Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.29 Bn | -2.06 | — | 0.29 Bn |
| 81 | AKBA | Akebia Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.27 Bn | -9.01 | 1.22 | 0.11 Bn |
| 82 | CELG-RI | Bristol Myers Squibb Co | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.25 Bn | 0.03 | 0.01 | -10.82 Bn |
| 83 | SIGA | Siga Technologies Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.24 Bn | — | — | 0.08 Bn |
| 84 | TNXP | Tonix Pharmaceuticals Holding Corp. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.22 Bn | -1.37 | 7.53 | 0.22 Bn |
| 85 | DERM | Journey Medical Corp | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.22 Bn | -59.75 | 3.20 | 0.19 Bn |
| 86 | NERV | Minerva Neurosciences, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.21 Bn | -32.50 | — | 0.21 Bn |
| 87 | ACOG | Alpha Cognition Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.21 Bn | -7.49 | 15.36 | 0.16 Bn |
| 88 | SLGL | Sol-Gel Technologies Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.19 Bn | -18.26 | 106.68 | 0.14 Bn |
| 89 | MCUJF | Medicure Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.19 Bn | -35.91 | 8.18 | 0.19 Bn |
| 90 | CRDL | Cardiol Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.19 Bn | -7.21 | — | 0.17 Bn |
| 91 | LONA | LeonaBio, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.19 Bn | -1.53 | — | 0.14 Bn |
| 92 | LENZ | LENZ Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.18 Bn | -1.41 | 8.48 | 0.18 Bn |
| 93 | MENS | Jyong Biotech Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.17 Bn | -44.35 | — | 0.17 Bn |
| 94 | BMEA | Biomea Fusion, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.14 Bn | -2.54 | — | 0.14 Bn |
| 95 | VANI | Vivani Medical, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.13 Bn | -4.73 | — | 0.11 Bn |
| 96 | NTHI | Neonc Technologies Holdings, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.13 Bn | -2.86 | — | 0.13 Bn |
| 97 | AARD | Aardvark Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.12 Bn | -1.71 | — | 0.05 Bn |
| 98 | VRCA | Verrica Pharmaceuticals Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.11 Bn | -3.63 | 3.76 | 0.10 Bn |
| 99 | CPIX | Cumberland Pharmaceuticals Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.10 Bn | -9.44 | 3.25 | 0.10 Bn |
| 100 | RGC | Regencell Bioscience Holdings Ltd | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | — | — | 0.09 Bn |
| 101 | CGTX | Cognition Therapeutics Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | -2.51 | — | 0.09 Bn |
| 102 | PTHS | Pelthos Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | -0.78 | 1.61 | 0.06 Bn |
| 103 | TENX | Tenax Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.08 Bn | -1.30 | — | 0.08 Bn |
| 104 | MNOV | Medicinova Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.08 Bn | -6.94 | 91.29 | 0.08 Bn |
| 105 | PLRX | Pliant Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.07 Bn | -0.76 | — | 0.07 Bn |
| 106 | PMVP | PMV Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.07 Bn | -1.14 | — | -0.01 Bn |
| 107 | CING | Cingulate Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.07 Bn | -3.10 | — | 0.07 Bn |
| 108 | BOLD | Boundless Bio, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.06 Bn | -1.00 | — | 0.06 Bn |
| 109 | VERU | Veru Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.06 Bn | 124.51 | — | 0.04 Bn |
| 110 | GOSS | Gossamer Bio, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.06 Bn | -0.33 | 1.05 | 0.00 Bn |
| 111 | ANVS | Annovis Bio, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | -1.07 | — | 0.05 Bn |
| 112 | KPTI | Karyopharm Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | -0.26 | 0.35 | 0.05 Bn |
| 113 | CLNN | Clene Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | -1.40 | 222.77 | 0.05 Bn |
| 114 | APRE | Aprea Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -3.43 | — | 0.04 Bn |
| 115 | IXHL | Incannex Healthcare Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -0.83 | — | 0.04 Bn |
| 116 | SCLX | Scilex Holding Co | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -0.08 | 1.20 | -0.07 Bn |
| 117 | GRCE | Grace Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -1.82 | — | 0.04 Bn |
| 118 | CPHI | China Pharma Holdings, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -7.57 | 8.65 | 0.03 Bn |
| 119 | UG | United Guardian Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | 14.61 | 2.95 | 0.02 Bn |
| 120 | ACTU | Actuate Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -1.59 | — | 0.03 Bn |
| 121 | NSRX | Nasus Pharma Ltd | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -5.64 | — | 0.03 Bn |
| 122 | YARW | Yarrow Bioscience, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -1.30 | 54.16 | 0.00 Bn |
| 123 | CRVO | CervoMed Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -0.86 | 79.16 | 0.03 Bn |
| 124 | BYSI | BeyondSpring Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -3.07 | — | 0.03 Bn |
| 125 | TXMD | TherapeuticsMD, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -137.01 | 7.75 | 0.02 Bn |
| 126 | AYTU | Aytu Biopharma, Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.77 | 0.42 | 0.00 Bn |
| 127 | ALLR | Allarity Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -1.89 | 916.46 | 0.02 Bn |
| 128 | ATOS | Atossa Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.75 | — | 0.02 Bn |
| 129 | BFRI | Biofrontera Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -4.27 | 0.45 | 0.02 Bn |
| 130 | MIRA | Mira Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.55 | — | 0.01 Bn |
| 131 | TVRD | Tvardi Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.67 | — | 0.02 Bn |
| 132 | KPRX | Kiora Pharmaceuticals Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -1.47 | — | 0.02 Bn |
| 133 | INTI | Inhibitor Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -4.72 | — | 0.02 Bn |
| 134 | CTXR | Citius Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.34 | 2.19 | 0.02 Bn |
| 135 | ANEB | Anebulo Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -1.37 | — | 0.01 Bn |
| 136 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.82 | — | 0.01 Bn |
| 137 | CALC | CalciMedica, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.35 | -8.60 | -0.01 Bn |
| 138 | CURX | Curanex Pharmaceuticals Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.95 | — | 0.00 Bn |
| 139 | ADXN | Addex Therapeutics Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | 0.05 | — | 0.01 Bn |
| 140 | ACXP | Acurx Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.79 | — | 0.01 Bn |
| 141 | TRAW | Traws Pharma, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.35 | — | 0.00 Bn |
| 142 | PCSA | Processa Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.42 | — | 0.01 Bn |
| 143 | PULM | Pulmatrix, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -1.27 | — | 0.01 Bn |
| 144 | TCRT | Alaunos Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.99 | 1,337.11 | 0.00 Bn |
| 145 | CVKD | Cadrenal Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.31 | — | 0.00 Bn |
| 146 | BICX | BioCorRx Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -1.64 | 6.70 | 0.00 Bn |
| 147 | CASIF | CASI Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.02 | 0.12 | 0.00 Bn |
| 148 | SKVI | Skinvisible, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -2.25 | 116.18 | 0.00 Bn |
| 149 | OGEN | Oragenics Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.22 | — | 0.00 Bn |
| 150 | UPC | Universe Pharmaceuticals INC | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | — | — | -1,490.23 Bn |
| 151 | CANF | Can-Fite BioPharma Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.21 | 5.02 | -0.01 Bn |
| 152 | MTNB | Matinas BioPharma Holdings, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.16 | — | 0.00 Bn |
| 153 | ENSC | Ensysce Biosciences, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | — | — | 0.00 Bn |
| 154 | SPRC | SciSparc Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.05 | 0.77 | 0.00 Bn |
| 155 | NCEL | NewcelX Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.06 | — | 0.00 Bn |
| 156 | JAGX | Jaguar Health, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.01 | 0.02 | -0.01 Bn |
| 157 | GLMD | Galmed Pharmaceuticals Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | — | — | -0.01 Bn |
| 158 | CDT | CDT Equity Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.01 | — | 0.00 Bn |
| 159 | GCAN | Trafalgar International, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -1.77 | — | 0.00 Bn |
| 160 | SXTC | China SXT Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | 0.00 | 0.03 | -0.03 Bn |
| 161 | CMND | Clearmind Medicine Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | 0.00 | — | -0.01 Bn |
| 162 | GILD | Gilead Sciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 187.23 Bn | -64.67 | 6.15 | 184.05 Bn |
| 163 | VRTX | Vertex Pharmaceuticals Inc / Ma | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 138.92 Bn | 31.54 | 11.04 | 131.07 Bn |
| 164 | TEVA | Teva Pharmaceutical Industries Ltd | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 42.46 Bn | 61.00 | 2.45 | 38.80 Bn |
| 165 | ALC | Alcon Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 34.90 Bn | 29.30 | 3.24 | 33.44 Bn |
| 166 | GEHC | GE HealthCare Technologies Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 31.14 Bn | 15.18 | 1.46 | 29.04 Bn |
| 167 | INSM | INSMED Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 27.41 Bn | -31.32 | 24.10 | 26.25 Bn |
| 168 | ROIV | Roivant Sciences Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 25.26 Bn | -17.02 | 2,312.85 | 25.26 Bn |
| 169 | VTRS | Viatris Inc | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 19.74 Bn | -48.05 | 1.34 | 18.85 Bn |
| 170 | BWXT | BWX Technologies, Inc. | secondary | I-39 | Clean Energy Equipment | IG-10 | 14.45 Bn | 40.58 | 4.11 | 13.84 Bn |
| 171 | GKOS | GLAUKOS Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 10.48 Bn | -66.51 | 17.09 | 10.36 Bn |
| 172 | PRAX | Praxis Precision Medicines, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 10.26 Bn | -26.89 | — | 9.50 Bn |
| 173 | BLRX | BioLineRx Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 6.47 Bn | -722.57 | 4,648.95 | 6.47 Bn |
| 174 | BLCO | Bausch & Lomb Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 6.46 Bn | -39.65 | 1.21 | 6.09 Bn |
| 175 | AMRX | Amneal Pharmaceuticals, Inc. | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 5.56 Bn | 25.80 | 1.78 | 5.43 Bn |
| 176 | ERAS | Erasca, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 5.04 Bn | -17.55 | — | 5.04 Bn |
| 177 | DNLI | Denali Therapeutics Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 4.18 Bn | -8.17 | 1,159.80 | 4.18 Bn |
| 178 | RCUS | Arcus Biosciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.73 Bn | -8.11 | 31.88 | 3.03 Bn |
| 179 | IMNM | Immunome Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.06 Bn | -11.33 | 593.06 | 2.54 Bn |
| 180 | ZLAB | Zai Lab Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.95 Bn | -15.66 | 6.55 | 2.24 Bn |
| 181 | NRIX | Nurix Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.87 Bn | -8.42 | 78.13 | 2.43 Bn |
| 182 | SLS | SELLAS Life Sciences Group, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.62 Bn | -80.66 | — | 2.62 Bn |
| 183 | CURLF | Curaleaf Holdings, Inc. | secondary | S-09 | Tobacco and Cannabis | SG-04 | 2.58 Bn | -21.76 | 1.97 | 2.48 Bn |
| 184 | BCRX | Biocryst Pharmaceuticals Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.54 Bn | -6.61 | 4.76 | 2.19 Bn |
| 185 | BHC | Bausch Health Companies Inc. | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 2.46 Bn | -2.25 | 0.23 | 0.62 Bn |
| 186 | BHVN | Biohaven Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.36 Bn | -4.02 | — | 2.09 Bn |
| 187 | FMS | Fresenius Medical Care AG | secondary | H-14 | Healthcare Providers | HG-04 | 2.21 Bn | 1.85 | 0.08 | 0.38 Bn |
| 188 | ZBIO | Zenas BioPharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.08 Bn | -5.00 | 2,080.81 | 2.08 Bn |
| 189 | RARE | Ultragenyx Pharmaceutical Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.59 Bn | -3.43 | 2.21 | 1.29 Bn |
| 190 | AAPG | Ascentage Pharma Group International | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.57 Bn | -9.11 | 20.12 | 1.29 Bn |
| 191 | ANIP | Ani Pharmaceuticals Inc | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 1.51 Bn | 13.96 | 1.54 | 1.15 Bn |
| 192 | AVBP | ArriVent BioPharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.48 Bn | -9.04 | — | 1.48 Bn |
| 193 | OMER | Omeros Corp | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.38 Bn | 80.85 | 35.91 | 1.38 Bn |
| 194 | CRVS | Corvus Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.34 Bn | -28.11 | — | 1.13 Bn |
| 195 | MNPR | Monopar Therapeutics | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.01 Bn | -72.79 | — | 0.96 Bn |
| 196 | ACRS | Aclaris Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.88 Bn | -11.04 | 106.89 | 0.88 Bn |
| 197 | OCS | Oculis Holding AG | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.64 Bn | -364,483.91 | — | 0.35 Bn |
| 198 | DCTH | Delcath Systems, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.59 Bn | 1,189.74 | 6.16 | 0.49 Bn |
| 199 | PRLD | Prelude Therapeutics Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.54 Bn | -8.00 | 24.04 | 0.26 Bn |
| 200 | ANL | Adlai Nortye Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.50 Bn | -10.27 | 78.36 | 0.26 Bn |
| 201 | EVMN | Evommune, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.45 Bn | -4.74 | 44.84 | 0.25 Bn |
| 202 | IRD | Opus Genetics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.45 Bn | -4.59 | 45.29 | 0.36 Bn |
| 203 | SWKHL | SWK Holdings Corp | secondary | F-06 | Lending and Credit | FG-02 | 0.31 Bn | -332.50 | 7.47 | 0.27 Bn |
| 204 | FTH | Faeth Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.23 Bn | -1.17 | — | 0.23 Bn |
| 205 | TNYA | Tenaya Therapeutics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.15 Bn | -1.46 | 112.42 | 0.15 Bn |
| 206 | IFRX | InflaRx N.V. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.15 Bn | -3.69 | 1,890.67 | -0.04 Bn |
| 207 | SPRB | Spruce Biosciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.14 Bn | -2.89 | — | 0.14 Bn |
| 208 | PYPD | PolyPid Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | 2.81 | — | 0.08 Bn |
| 209 | FBIO | Fortress Biotech, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | 10.33 | 1.25 | -0.11 Bn |
| 210 | AIFC | AI Financial Corp | secondary | T-54 | Fintech | TG-09 | 0.08 Bn | -0.09 | 3.90 | 0.07 Bn |
| 211 | PTN | Palatin Technologies Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | -7.84 | 3.82 | 0.05 Bn |
| 212 | APLM | Apollomics Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -3.67 | 4.72 | 0.04 Bn |
| 213 | BETRF | BetterLife Pharma Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -21.82 | — | 0.03 Bn |
| 214 | KAPA | Kairos Pharma, LTD. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -5.68 | 0.35 | 0.03 Bn |
| 215 | MDBH | MDB Capital Holdings, LLC | secondary | F-17 | Capital Markets | FG-05 | 0.02 Bn | -1.29 | — | 0.01 Bn |
| 216 | QCLS | Q/C Technologies, Inc. | secondary | T-01 | Semiconductors | TG-01 | 0.01 Bn | -2.05 | — | 0.01 Bn |
| 217 | RKTO | Rocket One Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -1.08 | — | 0.01 Bn |
| 218 | INM | InMed Pharmaceuticals Inc. | secondary | M-02 | Chemicals | MG-01 | 0.01 Bn | -0.69 | — | 0.00 Bn |
| 219 | TPST | Tempest Therapeutics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.28 | — | 0.00 Bn |
| 220 | BTAI | BioXcel Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.03 | 2.89 | 0.00 Bn |
| 221 | ZCMD | Zhongchao Inc. | secondary | T-27 | Vertical Software | TG-05 | 0.00 Bn | -0.01 | 0.00 | -0.01 Bn |